Request Free Sample ×
Thyroid Test Market Research Report - Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Thyroid Test Market

ID: MRFR/HC/7076-HCR
111 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Thyroid Test Market Research Report Information By Type (TSH Tests, T4 Tests, T3 Tests, Other) and By End-User (Hospital, Diagnostic Laboratories, and Research Laboratories & Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Thyroid Test Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Test Type (USD Million)
  49.     4.1.1 Thyroid Stimulating Hormone Test
  50.     4.1.2 Free Thyroxine Test
  51.     4.1.3 Total Triiodothyronine Test
  52.     4.1.4 Thyroid Antibody Test
  53.   4.2 Healthcare, BY End User (USD Million)
  54.     4.2.1 Hospitals
  55.     4.2.2 Diagnostic Laboratories
  56.     4.2.3 Home Care Settings
  57.     4.2.4 Research Institutions
  58.   4.3 Healthcare, BY Sample Type (USD Million)
  59.     4.3.1 Blood Sample
  60.     4.3.2 Saliva Sample
  61.     4.3.3 Urine Sample
  62.   4.4 Healthcare, BY Technology (USD Million)
  63.     4.4.1 Immunoassay
  64.     4.4.2 Molecular Diagnostics
  65.     4.4.3 Point-of-Care Testing
  66.   4.5 Healthcare, BY Region (USD Million)
  67.     4.5.1 North America
  68.       4.5.1.1 US
  69.       4.5.1.2 Canada
  70.     4.5.2 Europe
  71.       4.5.2.1 Germany
  72.       4.5.2.2 UK
  73.       4.5.2.3 France
  74.       4.5.2.4 Russia
  75.       4.5.2.5 Italy
  76.       4.5.2.6 Spain
  77.       4.5.2.7 Rest of Europe
  78.     4.5.3 APAC
  79.       4.5.3.1 China
  80.       4.5.3.2 India
  81.       4.5.3.3 Japan
  82.       4.5.3.4 South Korea
  83.       4.5.3.5 Malaysia
  84.       4.5.3.6 Thailand
  85.       4.5.3.7 Indonesia
  86.       4.5.3.8 Rest of APAC
  87.     4.5.4 South America
  88.       4.5.4.1 Brazil
  89.       4.5.4.2 Mexico
  90.       4.5.4.3 Argentina
  91.       4.5.4.4 Rest of South America
  92.     4.5.5 MEA
  93.       4.5.5.1 GCC Countries
  94.       4.5.5.2 South Africa
  95.       4.5.5.3 Rest of MEA
  96. 5 SECTION V: COMPETITIVE ANALYSIS
  97.   5.1 Competitive Landscape
  98.     5.1.1 Overview
  99.     5.1.2 Competitive Analysis
  100.     5.1.3 Market share Analysis
  101.     5.1.4 Major Growth Strategy in the Healthcare
  102.     5.1.5 Competitive Benchmarking
  103.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  104.     5.1.7 Key developments and growth strategies
  105.       5.1.7.1 New Product Launch/Service Deployment
  106.       5.1.7.2 Merger & Acquisitions
  107.       5.1.7.3 Joint Ventures
  108.     5.1.8 Major Players Financial Matrix
  109.       5.1.8.1 Sales and Operating Income
  110.       5.1.8.2 Major Players R&D Expenditure. 2023
  111.   5.2 Company Profiles
  112.     5.2.1 Abbott Laboratories (US)
  113.       5.2.1.1 Financial Overview
  114.       5.2.1.2 Products Offered
  115.       5.2.1.3 Key Developments
  116.       5.2.1.4 SWOT Analysis
  117.       5.2.1.5 Key Strategies
  118.     5.2.2 Roche Diagnostics (CH)
  119.       5.2.2.1 Financial Overview
  120.       5.2.2.2 Products Offered
  121.       5.2.2.3 Key Developments
  122.       5.2.2.4 SWOT Analysis
  123.       5.2.2.5 Key Strategies
  124.     5.2.3 Siemens Healthineers (DE)
  125.       5.2.3.1 Financial Overview
  126.       5.2.3.2 Products Offered
  127.       5.2.3.3 Key Developments
  128.       5.2.3.4 SWOT Analysis
  129.       5.2.3.5 Key Strategies
  130.     5.2.4 Thermo Fisher Scientific (US)
  131.       5.2.4.1 Financial Overview
  132.       5.2.4.2 Products Offered
  133.       5.2.4.3 Key Developments
  134.       5.2.4.4 SWOT Analysis
  135.       5.2.4.5 Key Strategies
  136.     5.2.5 Quest Diagnostics (US)
  137.       5.2.5.1 Financial Overview
  138.       5.2.5.2 Products Offered
  139.       5.2.5.3 Key Developments
  140.       5.2.5.4 SWOT Analysis
  141.       5.2.5.5 Key Strategies
  142.     5.2.6 LabCorp (US)
  143.       5.2.6.1 Financial Overview
  144.       5.2.6.2 Products Offered
  145.       5.2.6.3 Key Developments
  146.       5.2.6.4 SWOT Analysis
  147.       5.2.6.5 Key Strategies
  148.     5.2.7 Bio-Rad Laboratories (US)
  149.       5.2.7.1 Financial Overview
  150.       5.2.7.2 Products Offered
  151.       5.2.7.3 Key Developments
  152.       5.2.7.4 SWOT Analysis
  153.       5.2.7.5 Key Strategies
  154.     5.2.8 PerkinElmer (US)
  155.       5.2.8.1 Financial Overview
  156.       5.2.8.2 Products Offered
  157.       5.2.8.3 Key Developments
  158.       5.2.8.4 SWOT Analysis
  159.       5.2.8.5 Key Strategies
  160.   5.3 Appendix
  161.     5.3.1 References
  162.     5.3.2 Related Reports
  163. 6 LIST OF FIGURES
  164.   6.1 MARKET SYNOPSIS
  165.   6.2 NORTH AMERICA MARKET ANALYSIS
  166.   6.3 US MARKET ANALYSIS BY TEST TYPE
  167.   6.4 US MARKET ANALYSIS BY END USER
  168.   6.5 US MARKET ANALYSIS BY SAMPLE TYPE
  169.   6.6 US MARKET ANALYSIS BY TECHNOLOGY
  170.   6.7 CANADA MARKET ANALYSIS BY TEST TYPE
  171.   6.8 CANADA MARKET ANALYSIS BY END USER
  172.   6.9 CANADA MARKET ANALYSIS BY SAMPLE TYPE
  173.   6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
  174.   6.11 EUROPE MARKET ANALYSIS
  175.   6.12 GERMANY MARKET ANALYSIS BY TEST TYPE
  176.   6.13 GERMANY MARKET ANALYSIS BY END USER
  177.   6.14 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
  178.   6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY
  179.   6.16 UK MARKET ANALYSIS BY TEST TYPE
  180.   6.17 UK MARKET ANALYSIS BY END USER
  181.   6.18 UK MARKET ANALYSIS BY SAMPLE TYPE
  182.   6.19 UK MARKET ANALYSIS BY TECHNOLOGY
  183.   6.20 FRANCE MARKET ANALYSIS BY TEST TYPE
  184.   6.21 FRANCE MARKET ANALYSIS BY END USER
  185.   6.22 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
  186.   6.23 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  187.   6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE
  188.   6.25 RUSSIA MARKET ANALYSIS BY END USER
  189.   6.26 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
  190.   6.27 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
  191.   6.28 ITALY MARKET ANALYSIS BY TEST TYPE
  192.   6.29 ITALY MARKET ANALYSIS BY END USER
  193.   6.30 ITALY MARKET ANALYSIS BY SAMPLE TYPE
  194.   6.31 ITALY MARKET ANALYSIS BY TECHNOLOGY
  195.   6.32 SPAIN MARKET ANALYSIS BY TEST TYPE
  196.   6.33 SPAIN MARKET ANALYSIS BY END USER
  197.   6.34 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
  198.   6.35 SPAIN MARKET ANALYSIS BY TECHNOLOGY
  199.   6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
  200.   6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
  201.   6.38 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
  202.   6.39 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
  203.   6.40 APAC MARKET ANALYSIS
  204.   6.41 CHINA MARKET ANALYSIS BY TEST TYPE
  205.   6.42 CHINA MARKET ANALYSIS BY END USER
  206.   6.43 CHINA MARKET ANALYSIS BY SAMPLE TYPE
  207.   6.44 CHINA MARKET ANALYSIS BY TECHNOLOGY
  208.   6.45 INDIA MARKET ANALYSIS BY TEST TYPE
  209.   6.46 INDIA MARKET ANALYSIS BY END USER
  210.   6.47 INDIA MARKET ANALYSIS BY SAMPLE TYPE
  211.   6.48 INDIA MARKET ANALYSIS BY TECHNOLOGY
  212.   6.49 JAPAN MARKET ANALYSIS BY TEST TYPE
  213.   6.50 JAPAN MARKET ANALYSIS BY END USER
  214.   6.51 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
  215.   6.52 JAPAN MARKET ANALYSIS BY TECHNOLOGY
  216.   6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
  217.   6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
  218.   6.55 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
  219.   6.56 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
  220.   6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE
  221.   6.58 MALAYSIA MARKET ANALYSIS BY END USER
  222.   6.59 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
  223.   6.60 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
  224.   6.61 THAILAND MARKET ANALYSIS BY TEST TYPE
  225.   6.62 THAILAND MARKET ANALYSIS BY END USER
  226.   6.63 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
  227.   6.64 THAILAND MARKET ANALYSIS BY TECHNOLOGY
  228.   6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE
  229.   6.66 INDONESIA MARKET ANALYSIS BY END USER
  230.   6.67 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
  231.   6.68 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
  232.   6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE
  233.   6.70 REST OF APAC MARKET ANALYSIS BY END USER
  234.   6.71 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
  235.   6.72 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
  236.   6.73 SOUTH AMERICA MARKET ANALYSIS
  237.   6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE
  238.   6.75 BRAZIL MARKET ANALYSIS BY END USER
  239.   6.76 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
  240.   6.77 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
  241.   6.78 MEXICO MARKET ANALYSIS BY TEST TYPE
  242.   6.79 MEXICO MARKET ANALYSIS BY END USER
  243.   6.80 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
  244.   6.81 MEXICO MARKET ANALYSIS BY TECHNOLOGY
  245.   6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE
  246.   6.83 ARGENTINA MARKET ANALYSIS BY END USER
  247.   6.84 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
  248.   6.85 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
  249.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
  250.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  251.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
  252.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  253.   6.90 MEA MARKET ANALYSIS
  254.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
  255.   6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
  256.   6.93 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
  257.   6.94 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
  258.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
  259.   6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
  260.   6.97 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
  261.   6.98 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
  262.   6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE
  263.   6.100 REST OF MEA MARKET ANALYSIS BY END USER
  264.   6.101 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
  265.   6.102 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
  266.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  267.   6.104 RESEARCH PROCESS OF MRFR
  268.   6.105 DRO ANALYSIS OF HEALTHCARE
  269.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  270.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  271.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  272.   6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
  273.   6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Million)
  274.   6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
  275.   6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
  276.   6.113 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
  277.   6.114 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
  278.   6.115 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  279.   6.116 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  280.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  281. 7 LIST OF TABLES
  282.   7.1 LIST OF ASSUMPTIONS
  283.     7.1.1
  284.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  285.     7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  286.     7.2.2 BY END USER, 2025-2035 (USD Million)
  287.     7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  288.     7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  289.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  290.     7.3.1 BY TEST TYPE, 2025-2035 (USD Million)
  291.     7.3.2 BY END USER, 2025-2035 (USD Million)
  292.     7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  293.     7.3.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  294.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  295.     7.4.1 BY TEST TYPE, 2025-2035 (USD Million)
  296.     7.4.2 BY END USER, 2025-2035 (USD Million)
  297.     7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  298.     7.4.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  299.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  300.     7.5.1 BY TEST TYPE, 2025-2035 (USD Million)
  301.     7.5.2 BY END USER, 2025-2035 (USD Million)
  302.     7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  303.     7.5.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  304.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  305.     7.6.1 BY TEST TYPE, 2025-2035 (USD Million)
  306.     7.6.2 BY END USER, 2025-2035 (USD Million)
  307.     7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  308.     7.6.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  309.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  310.     7.7.1 BY TEST TYPE, 2025-2035 (USD Million)
  311.     7.7.2 BY END USER, 2025-2035 (USD Million)
  312.     7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  313.     7.7.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  314.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  315.     7.8.1 BY TEST TYPE, 2025-2035 (USD Million)
  316.     7.8.2 BY END USER, 2025-2035 (USD Million)
  317.     7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  318.     7.8.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  319.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  320.     7.9.1 BY TEST TYPE, 2025-2035 (USD Million)
  321.     7.9.2 BY END USER, 2025-2035 (USD Million)
  322.     7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  323.     7.9.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  324.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  325.     7.10.1 BY TEST TYPE, 2025-2035 (USD Million)
  326.     7.10.2 BY END USER, 2025-2035 (USD Million)
  327.     7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  328.     7.10.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  329.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  330.     7.11.1 BY TEST TYPE, 2025-2035 (USD Million)
  331.     7.11.2 BY END USER, 2025-2035 (USD Million)
  332.     7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  333.     7.11.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  334.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  335.     7.12.1 BY TEST TYPE, 2025-2035 (USD Million)
  336.     7.12.2 BY END USER, 2025-2035 (USD Million)
  337.     7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  338.     7.12.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  339.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  340.     7.13.1 BY TEST TYPE, 2025-2035 (USD Million)
  341.     7.13.2 BY END USER, 2025-2035 (USD Million)
  342.     7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  343.     7.13.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  344.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  345.     7.14.1 BY TEST TYPE, 2025-2035 (USD Million)
  346.     7.14.2 BY END USER, 2025-2035 (USD Million)
  347.     7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  348.     7.14.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  349.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  350.     7.15.1 BY TEST TYPE, 2025-2035 (USD Million)
  351.     7.15.2 BY END USER, 2025-2035 (USD Million)
  352.     7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  353.     7.15.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  354.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  355.     7.16.1 BY TEST TYPE, 2025-2035 (USD Million)
  356.     7.16.2 BY END USER, 2025-2035 (USD Million)
  357.     7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  358.     7.16.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  359.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  360.     7.17.1 BY TEST TYPE, 2025-2035 (USD Million)
  361.     7.17.2 BY END USER, 2025-2035 (USD Million)
  362.     7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  363.     7.17.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  364.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  365.     7.18.1 BY TEST TYPE, 2025-2035 (USD Million)
  366.     7.18.2 BY END USER, 2025-2035 (USD Million)
  367.     7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  368.     7.18.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  369.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  370.     7.19.1 BY TEST TYPE, 2025-2035 (USD Million)
  371.     7.19.2 BY END USER, 2025-2035 (USD Million)
  372.     7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  373.     7.19.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  374.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  375.     7.20.1 BY TEST TYPE, 2025-2035 (USD Million)
  376.     7.20.2 BY END USER, 2025-2035 (USD Million)
  377.     7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  378.     7.20.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  379.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  380.     7.21.1 BY TEST TYPE, 2025-2035 (USD Million)
  381.     7.21.2 BY END USER, 2025-2035 (USD Million)
  382.     7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  383.     7.21.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  384.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  385.     7.22.1 BY TEST TYPE, 2025-2035 (USD Million)
  386.     7.22.2 BY END USER, 2025-2035 (USD Million)
  387.     7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  388.     7.22.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  389.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  390.     7.23.1 BY TEST TYPE, 2025-2035 (USD Million)
  391.     7.23.2 BY END USER, 2025-2035 (USD Million)
  392.     7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  393.     7.23.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  394.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  395.     7.24.1 BY TEST TYPE, 2025-2035 (USD Million)
  396.     7.24.2 BY END USER, 2025-2035 (USD Million)
  397.     7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  398.     7.24.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  399.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  400.     7.25.1 BY TEST TYPE, 2025-2035 (USD Million)
  401.     7.25.2 BY END USER, 2025-2035 (USD Million)
  402.     7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  403.     7.25.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  404.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  405.     7.26.1 BY TEST TYPE, 2025-2035 (USD Million)
  406.     7.26.2 BY END USER, 2025-2035 (USD Million)
  407.     7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  408.     7.26.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  409.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  410.     7.27.1 BY TEST TYPE, 2025-2035 (USD Million)
  411.     7.27.2 BY END USER, 2025-2035 (USD Million)
  412.     7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  413.     7.27.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  414.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  415.     7.28.1 BY TEST TYPE, 2025-2035 (USD Million)
  416.     7.28.2 BY END USER, 2025-2035 (USD Million)
  417.     7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  418.     7.28.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  419.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  420.     7.29.1 BY TEST TYPE, 2025-2035 (USD Million)
  421.     7.29.2 BY END USER, 2025-2035 (USD Million)
  422.     7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  423.     7.29.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  424.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  425.     7.30.1 BY TEST TYPE, 2025-2035 (USD Million)
  426.     7.30.2 BY END USER, 2025-2035 (USD Million)
  427.     7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  428.     7.30.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  429.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  430.     7.31.1
  431.   7.32 ACQUISITION/PARTNERSHIP
  432.     7.32.1

Healthcare Market Segmentation

Healthcare By Test Type (USD Million, 2025-2035)

  • Thyroid Stimulating Hormone Test
  • Free Thyroxine Test
  • Total Triiodothyronine Test
  • Thyroid Antibody Test

Healthcare By End User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Institutions

Healthcare By Sample Type (USD Million, 2025-2035)

  • Blood Sample
  • Saliva Sample
  • Urine Sample

Healthcare By Technology (USD Million, 2025-2035)

  • Immunoassay
  • Molecular Diagnostics
  • Point-of-Care Testing

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓